These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17696918)

  • 21. nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up.
    Pacifico MD; Grover R; Richman PI; Buffa F; Daley FM; Wilson GD
    Melanoma Res; 2005 Oct; 15(5):435-40. PubMed ID: 16179871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity in prognostic histopathologic features of melanoma.
    Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
    J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY; Wang HC; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma.
    Sarris M; Scolyer RA; Konopka M; Thompson JF; Harper CG; Lee CS
    Melanoma Res; 2004 Feb; 14(1):23-7. PubMed ID: 15091190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
    Depasquale I; Thompson WD
    Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
    J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.
    Oba J; Nakahara T; Hayashida S; Kido M; Xie L; Takahara M; Uchi H; Miyazaki S; Abe T; Hagihara A; Moroi Y; Furue M
    J Am Acad Dermatol; 2011 Dec; 65(6):1152-60. PubMed ID: 21700362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
    Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
    Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
    Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular markers associated to prognosis of melanoma].
    Heenen M; Laporte M
    Ann Dermatol Venereol; 2003 Nov; 130(11):1025-31. PubMed ID: 14724537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognosis and invasion marker expression of cutaneous melanoma. Metastasis-associated genes (nm23, CD44v3, MMP2].
    Döme B; Somlai B; Tamásy A; Péter L; Tóvári J; Horváth A; Tímár J
    Orv Hetil; 1999 Jan; 140(5):235-40. PubMed ID: 10064977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes.
    Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O
    Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
    van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
    Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors in thin cutaneous malignant melanoma].
    Massi D; Franchi A; Santucci M
    Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.